Is ENvue Medical, Inc. (FEED) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 5.3% / 30% | 34.4% / 30% | 12.3% / 30% | 0.0% / 5% | ✗ NOT HALAL |
| DJIM | 5.3% / 33% | 34.4% / 33% | 12.3% / 33% | 0.0% / 5% | ✗ NOT HALAL |
| MSCI | 3.2% / 33% | 20.7% / 33% | 7.4% / 33% | 0.0% / 5% | ✓ HALAL |
| S&P | 5.3% / 33% | 34.4% / 33% | 12.3% / 33% | 0.0% / 5% | ✗ NOT HALAL |
| FTSE | 3.2% / 33% | 20.7% / 33% | 7.4% / 50% | 0.0% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 30.0% | |
| Operating Margin | -311.2% | |
| Net Margin | -251.9% | |
| Return on Equity (ROE) | -30.5% | |
| Return on Assets (ROA) | -20.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$3M |
| Free Cash Flow | -$3M |
| Total Debt | $116,000 |
| Debt-to-Equity | 7.5 |
| Current Ratio | 0.9 |
| Total Assets | $4M |
Price & Trading
| Last Close | $2.30 |
| 50-Day MA | $2.14 |
| 200-Day MA | $5.19 |
| Avg Volume | 10.4M |
| Beta | 2.3 |
|
52-Week Range
$0.99
| |
About ENvue Medical, Inc. (FEED)
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is designed to prevent bacterial colonization and biofilm formation in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it provides PainShield MD, a single patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; PainShield Plus, a dual patch-based therapeutic ultrasound technology; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally. ENvue Medical, Inc. was formerly known as NanoVibronix, Inc. and changed its name to ENvue Medical, Inc. in December 2025. The company was incorporated in 2003 and is based in Arlington Heights, Illinois.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is ENvue Medical, Inc. (FEED) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), ENvue Medical, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is ENvue Medical, Inc.'s debt ratio?
ENvue Medical, Inc.'s debt ratio is 5.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 3.2%.
What are ENvue Medical, Inc.'s key financial metrics?
ENvue Medical, Inc. has a market capitalization of $3M, and revenue of $3M. The company maintains a gross margin of 30.0% and a net margin of -251.9%. Return on equity stands at -30.5%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.